Vol.45, No.3, Nov. 2017
Partnership for NTDs drug discovery originated in Japan / The past, present and future of bioethics and research ethics (Part IV)
 
Contents
 
EditorialYamada H512-3Full text
 
Symposium at the 137th Annual Meeting of the Pharmaceutical Society of Japan
 Partnership for NTDs drug discovery originated in Japan

       Organizers:Yamada H,Kita K
515-58Abstract
 Front line of partnership for NTDs drug discovery originated in JapanYamada H518-20 
 Current status and issues of NTDs and therapeutic drugsKita K521-7 
 Role of DNDi for NTDs drug developmentYamada H528-31 
 NTD Drug Discovery BoosterMowbray CE532-7 
 Efforts of pharmaceutical companies for the research and development
  of the new therapeutic drugs to tackle life-threatening infectious diseases
Yamano Y538-44 
 Strategies and Projects for Access to Medicine at Takeda Pharmaceutical Company LimitedIkeura Y545-50 
 Development and provision of medicines for neglected tropical diseases in collaboration
  with external partners
Watanabe N 551-7  
 Closing remarksKita K558
 
Book review  
 “Access: How do good health technologies get to poor people in poor countries?”Yamada H559-60
 
Lecture  
 Japan-Initiated Global Clinical Trials Development Project
  -Current status and future prospects-
Fukushima M561-70Abstract
 
Survey report  
 Investigation of clinical research activity in major general hospitals in JapanIto K,Clinical Research
and Trials Facilitation Forum
571-608Abstract
 
Original  
 Threat of terrorism by using chemical and biological warfare agents:
  Bioluminescence assay as a military biodefense
Imamura O,Mwange VM609-15Full text
 
The past, present and future of bioethics and research ethics (Part IV)  
 How can we make the best use of clinical research results?Tsuda S,Doi O617-28Abstract
 Ethics and regulations of clinical research in South AfricaDhai A
(Trans. by Kurihara C)
629-47Abstract
 International comparative study on clinical trial and human subject protection regulations
  -International norms, Japan, United States, South Korea, Taiwan, and South Africa-
Kurihara C649-65Abstract
 
In Memoriam: Akira NakajimaKurihara M667-8
 
Instructions for authors[Japanese] & [English] 669-77Full text
 
Editor's noteGotoh E679Full text
 
[Electronic publications only]
Invited lecture
 Ethics and regulations of clinical research in South Africa Dhai A681-701
W15-W35
Full text


Back to Rinsho Hyoka(Clinical Evaluation) home page
Back to Contents